Eli Lilly | 销售成本



Cost Of Sales 更改 日
AbbVie USD 4B 394M 2025-03
Abbott USD 4.44B 502M 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Baxter International USD 1.74B 73M 2024-12
Biogen USD 629.3M 45.8M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 44M 21M 2025-03
J&J USD 7.3B 189M 2025-03
Medtronic USD 3.11B 339M 2025-04
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Novo Nordisk 12.89B 1.58B 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Prestige Brands USD 126.51M 2.76M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
United Therapeutics USD 277.5M 201.6M 2025-03
Zoetis USD 622M 85M 2025-03



Eli Lilly 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.